Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers
ABSTRACT Treatments targeting the Ebola virus may eventually be shown to work, but they will not have an impact on overall Ebola mortality in West Africa. Endothelial dysfunction is responsible for the fluid and electrolyte imbalances seen in Ebola patients. Because inexpensive generic statins and a...
Guardado en:
Autores principales: | David S. Fedson, Jeffrey R. Jacobson, Ole Martin Rordam, Steven M. Opal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/27173e9602ba445d929bca6c1f08fdec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reply to “Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?”
por: David S. Fedson, et al.
Publicado: (2016) -
Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?
por: Viroj Wiwanitkit
Publicado: (2016) -
Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
por: David S. Fedson, et al.
Publicado: (2020) -
Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection
por: David S. Fedson, et al.
Publicado: (2020) -
Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang C, et al.
Publicado: (2021)